Toxicology Drug Testing Market (Testing Type - In Vivo, In Vitro, and In Silico; Testing Method - Mass Spectroscopy, Electron Microscopy, Fluroscence Labelling, Immunohistochemistry, and Others; Product - Instruments, Reagents and Consumable, Animal Models, Software, and Others; Application - Genotoxicity, Cytotoxicity, ADME, Systemic Toxicity, Immunotoxicity, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

A recent report published by Infinium Global Research on toxicology drug testing market provides in-depth analysis of segments and sub-segments in the global as well as regional toxicology drug testing market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional toxicology drug testing market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global toxicology drug testing market.

Market Insight:

The toxicology drug testing market was valued at USD 34.74 billion in 2022 and is expected to reach USD 56.87 billion in 2030, with a CAGR of 5.54% during the forecast period 2023-2030.

Toxicology drug testing is the method that involves evaluation of biological samples such as urine, saliva, and blood to detect and identify the presence of drugs or toxic substances. This diagnostic procedure is essential for determining drug exposure, tracking medication compliance, spotting substance addiction, and guaranteeing worker safety. Numerous biological specimens are available for testing, providing flexibility based on the kind of study required and the drugs under investigation. The non-clinical safety studies such as bio-distribution and toxicology are mandatory before starting to the first human clinical trial. The toxicological studies are also considered while developing a new drug entity. Toxicology drug testing involves therapeutic drug monitoring, occupational drug screening, forensic investigations, and program monitoring for substance abuse treatment. Toxicology drug testing finds applications in various industries like pharmaceuticals, healthcare, Food and beverage industry, and agriculture.

The advancements in testing technologies fuels the growth of the toxicology drug testing market. Ongoing technological advancements in testing, such as the application of high-performance analytical techniques like Gas Chromatography-mass Spectrometry (GC-MS) and Liquid Chromatography-mass Spectrometry (LC-MS), significantly improve the sensitivity and specificity of drug testing. These technologies enable the detection of lower drug and metabolite concentrations, thereby reducing the possibility of false-positive or false-negative results. Additionally, the increase in demand for toxicology drug testing in the food and beverage industry drives the growth of the market. The food and beverage industry governed by strict regulations intended for ensure the safety of the products that people consume. Drug tests using toxicology are used to find dangerous ingredients, impurities, or residues in food items so that consumers are not exposed to unnecessary health risks. Furthermore, toxicology testing is crucial for preserving the food supply chain's integrity. However, the stringent regulatory requirement associated with toxicology drug testing apparatus and reagents may hamper the market growth. Health authorities and quality control groups constitute the regulatory bodies establish stringent guidelines for the development, manufacture, and use of toxicological drug testing reagents. For businesses involved in the market, ensuring adherence with these standards may be a challenging and resource-intensive task. Moreover, the increasing investment in R&D activities in new drug development and clinical trials creates lucrative opportunities for market growth. This conscious emphasis on innovation promotes the development of innovative treatments boosts treatment options, and positions pharmaceutical companies to address emerging healthcare needs, contributing to sustained market expansion and competitiveness.

Geographically, the toxicology drug testing market is segmented into North America, Europe, Asia Pacifica, and the Rest of the World. North America region is expected to hold the largest share in the toxicology drug testing market. The surge in demand for toxicological drug screening in biotechnological and pharmaceutical industries favors the market growth in the region. Growth in the market is driven by an increase in R&D efforts and collaboration among pharmaceutical companies. For instance, in March 2022, Texas Health and Service launched a public awareness campaign of $23.2 Million to prevent abuse of substance disorders. Meanwhile, the Asia Pacific region is expected to witness the fastest growth in the market. The emerging drug development by major market player and clinical research drive the market growth in the region. The expansion of the pharmaceutical drug pipeline industry and growing concerns about product safety are driving the growth of the market in the area.

Report Scope of the Toxicology Drug Testing Market:

Segment wise revenue contribution in the global toxicology drug testing market

The report on global toxicology drug testing market provides a detailed analysis of segments in the market based on Testing Type, Testing Method, Product, and Application.

Segmentation Based on Testing Type

·       In Vivo

·       In Vitro

·       In Silico

Segmentation Based on Testing Method

·       Mass Spectroscopy

·       Electron Microscopy

·       Fluroscence Labelling

·       Immunohistochemistry

·       Others

Segmentation Based on Product

·       Instruments

·       Reagents and Consumable

·       Animal Models

·       Software

·       Others

Segmentation Based on Application

·       Genotoxicity

·       Cytotoxicity

·       ADME

·       Systemic Toxicity

·       Immunotoxicity

·       Others

Company Profiled:

·       Evotec

·       Promega Corporation

·       Agilent Technologies, Inc.

·       Biorad Laboratories Inc.

·       Eurofins

·       DH Life Sciences, LLC.

·       Intertech Group Plc

·       Creative Biolabs

·       Laboratory Corporation of America Holdings

·       SGS SA

Report Highlights:

The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the toxicology drug testing market. Moreover, the study highlights current market trends and provides forecasts from 2023-2030. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.